MARKET

RADX

RADX

Radiopharm Theranostics Ltd
NASDAQ
4.750
-0.140
-2.86%
After Hours: 4.890 +0.14 +2.95% 16:46 03/13 EDT
OPEN
4.830
PREV CLOSE
4.890
HIGH
4.900
LOW
4.750
VOLUME
12.36K
TURNOVER
--
52 WEEK HIGH
16.25
52 WEEK LOW
3.496
MARKET CAP
56.12M
P/E (TTM)
-1.5472
1D
5D
1M
3M
1Y
5Y
1D
Radiopharm: 'Hold' As Theranostics Pipeline Has Several 2026 Milestones
Seeking Alpha · 3d ago
Radiopharm Theranostics publishes corporate presentation on its radiopharmaceutical theranostics pipeline and clinical trials
Reuters · 4d ago
Weekly Report: what happened at RADX last week (0302-0306)?
Weekly Report · 5d ago
Analysts Are Bullish on These Healthcare Stocks: Schrodinger (SDGR), Radiopharm Theranostics Limited Sponsored ADR (RADX)
TipRanks · 03/06 16:31
Weekly Report: what happened at RADX last week (0223-0227)?
Weekly Report · 03/02 09:57
Radiopharm Theranostics doses first patient in Phase 1/2a trial of 177Lu-BetaBart (RV-01)
Reuters · 02/25 19:50
Radiopharm Theranostics Doses First Participant In Phase 1/2 Clinical Study Of 177Lu-Betabart
Benzinga · 02/24 12:36
Radiopharm Theranostics Doses First Patient in Phase 1/2a Trial of 177Lu-BetaBart (RV-01)
Reuters · 02/24 12:30
More
About RADX
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.

Webull offers Radiopharm Theranostics Ltd stock information, including NASDAQ: RADX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RADX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RADX stock methods without spending real money on the virtual paper trading platform.